https://www.selleckchem.com/pr....oducts/Rosuvastatin-
Advances in treatment for hematological cancers warrant greater attention on survivorship concerns. The aims of this study were to describe survivorship concerns among hematological cancer survivors, identify subgroups of survivors with distinct classes of concerns, and examine sociodemographic and clinical differences across subgroups. We conducted a cross-sectional analysis of data from 1160 hematological cancer survivors, who rated their degree of concern regarding 20 physical, emotional, and practical changes.
Like
Comment
Share
